ANXA5 and Parkinson disease: Finally, ANXA5 (Annexin A5) is implicated in Parkinson’s disease (PD) and AD by controlling intracellular Ca2+ levels, attenuating α-Syn nuclear translocation and reducing Aβ aggregation.